Mesoderm development

pathway activity — cross-omics
GO:0007498Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Mesoderm development pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are FRMD6, LUZP1, and AHNAK2, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Mesoderm development activity versus FRMD6 in LSCC (Pearson r = 0.31).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCFRMD6 →+0.949+0.814<.001<.00135
LUADLUZP1 →+0.384+0.749<.001<.00135
LSCCAHNAK2 →+1.154+0.605.003.00435
PDACRAB40C →-0.225-0.349.002.00134
LUADLINC01094 →+0.522+0.572<.001.00634
LSCCPPFIBP1 →+0.547+0.651.009.00234
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0007498 vs FRMD6 — LSCC

Per-sample scatter of Mesoderm development activity vs FRMD6 in LSCC.

Explore this scatter interactively →

Exploration